Introduction Insulin therapy plays an irreplaceable role in glycaemic control among older
adults with type 2 diabetes mellitus (T2DM) and can be administered by either multiple daily …

Introduction Insulin therapy plays an irreplaceable role in glycaemic control among older
adults with type 2 diabetes mellitus (T2DM) and can be administered by either multiple daily …

Background As an important part of diabetes treatment, insulin can be administered either
by multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII) via an …

OBJECTIVES: It is generally accepted that in adult type 1 diabetes patients (T1D) continuous
subcutaneous insulin infusion (CSII) via a personal pump is more effective than the multiple …

Some evidence that continuous subcutaneous insulin infusion for type I diabetes improves
glycaemic control compared with multiple daily injections, but few trials have compared CSII …

Diabetes mellitus (DM) has a growing prevalence worldwide, even in developing countries.
Many antidiabetic agents are used to improve glycemic control; however, in cases of an …

Aims We compared the effects of continuous subcutaneous insulin infusion (CSII) with those
of multiple daily insulin (MDI) injections on glycaemic control, risk of hypoglycaemic …

Aim To compare clinical characteristics and outcomes in adults with type 1 diabetes aged≥
60 years using continuous subcutaneous insulin infusion (CSII) vs. insulin injection therapy …

BACKGROUND: Insulin is necessary for patients with type 1 diabetes mellitus (T1DM) in
residual lifetime, and it is dispute the superiority and inferiority of multiple daily injections …

Meta-analyses of clinical trials comparing CSII with traditional insulin injections usually show
a small, but significant advantage of CSII with respect to HbA1c and risk of severe …